Active, not recruitingPHASE2, PHASE3NCT03418779

Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD

Studying IgA Nephropathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Principal Investigator
Jie Wang
Guang anmen Hospital, China Academy of Chinese Medical Sciences
Intervention
The Yi-Qi-Qing-Jie herbal compound(drug)
Enrollment
60 enrolled
Eligibility
18-70 years · All sexes
Timeline
2019 – 2024

Study locations (1)

Collaborators

China Academy of Chinese Medical Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03418779 on ClinicalTrials.gov

Other trials for IgA Nephropathy

Additional recruiting or active studies for the same condition.

See all trials for IgA Nephropathy →

← Back to all trials